Verrica Pharmaceuticals, Inc. (VRCA)
5.90
-0.12
(-1.99%)
USD |
NASDAQ |
May 21, 16:00
5.915
+0.02
(+0.25%)
After-Hours: 19:59
Verrica Pharmaceuticals Research and Development Expense (TTM) : 10.43M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Lipocine, Inc. | 10.23M |
| Cognition Therapeutics, Inc. | 32.45M |
| Corcept Therapeutics, Inc. | 260.44M |
| Assertio Holdings, Inc. | 1.706M |
| Johnson & Johnson | 14.99B |